Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Obalon Therapeutics Inc.

    NASDAQ: OBLN · Real-Time Price · USD
    3.05
    -0.19 (-5.86%)
    At close: Jun 16, 2021, 6:00 AM

    Obalon Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2021 Q1 2021
    Period Ending Jun 30, 2021 Mar 31, 2021
    Revenue
    		 108.53K 808K
    Cost of Revenue
    		 43.38K 465K
    Gross Profit
    		 65.15K 343K
    Operating Income
    		 -10.75M -9.9M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -7.06M -11.24M
    Net Income
    		 -7.06M -11.24M
    Selling & General & Admin
    		 6.58M 8.94M
    Research & Development
    		 540.1K 1.3M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 7.12M 10.24M
    Interest Expense
    		 -172 n/a
    Selling & Marketing Expenses
    		 1.44K n/a
    Cost & Expenses
    		 7.16M 10.71M
    Income Tax Expense
    		 28.00 n/a
    Shares Outstanding (Basic)
    		 9.44M 9.44M
    Shares Outstanding (Diluted)
    		 9.44M 9.44M
    EPS (Basic)
    		 -0.81 -1.35
    EPS (Diluted)
    		 -0.81 -1.35
    EBITDA
    		 -6.6M -10.46M
    EBIT
    		 -7.06M -7.05M
    Depreciation & Amortization
    		 457K 784K

    Add to Watchlist